Correction of the oxidation stress by trimetazidine in blood of patients with after myocardial infarction cardiosclerosis
- Authors: Davydkin I.L.1, Fatenkov V.N.1
-
Affiliations:
- Samara State Medical University
- Issue: Vol 82, No 5 (2001)
- Pages: 344-347
- Section: Articles
- URL: https://journals.rcsi.science/kazanmedj/article/view/84062
- DOI: https://doi.org/10.17816/kazmj84062
- ID: 84062
Cite item
Full Text
Abstract
The results of studies of the possibilities and mechanisms of correcting the oxidation stress in patients with cardiosclerosis after myocardial infarction, correlating with stable stress stenocardia of the 111 functional class are given. The treatment by trimetazidin of 34 patients in the daily dose of 60 mg within two months is carried out. Trimetazidine treatment in patients with angina after myocardial infarction decreases indices of metabolic oxidative stress. Trimetazidine treatment is accompanied by decrease in incidence and severity of angina and increase of physical tolerance.
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
I. L. Davydkin
Samara State Medical University
Author for correspondence.
Email: info@eco-vector.com
Russian Federation
V. N. Fatenkov
Samara State Medical University
Email: info@eco-vector.com
Russian Federation
References
Supplementary files
